(2R,3S)-3-(dibenzylamino)-5-methylhexan-2-ol | 111085-50-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2R,3S)-3-(dibenzylamino)-5-methylhexan-2-ol
• CAS: 111085-50-8
• 化学式: C₂₁H₂₉NO
• 分子量: 311.467
• InChiKey: LJBDBBNFYJDTST-NQIIRXRSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  23
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2R,3S)-3-(dibenzylamino)-5-methylhexan-2-ol 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 以62%的产率得到(2R,3S)-3-amino-5-methylhexan-2-ol
  参考文献：
  名称：

  Discovery of (S)-4-isobutyloxazolidin-2-one as a novel leucyl-tRNA synthetase (LRS)-targeted mTORC1 inhibitor

  摘要：

  A series of leucinol analogs were investigated as leucyl-tRNA synthetase-targeted mTORC1 inhibitors. Among them, compound 5, (S)-4-isobutyloxazolidin-2-one, showed the most potent inhibition on the mTORC1 pathway in a concentration-dependent manner. Compound 5 inhibited downstream phosphorylation of mTORC1 by blocking leucine-sensing ability of LRS, without affecting the catalytic activity of LRS. In addition, compound 5 exhibited cytotoxicity against rapamycin-resistant colon cancer cells, suggesting that LRS has the potential to serve as a novel therapeutic target. (C) 2016 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2016.05.011
• 作为产物：
  描述：

  L-亮氨醇 在 草酰氯 、 potassium carbonate 、 二甲基亚砜 、 三乙胺 作用下， 以 甲醇 、 乙醚 、 水 为溶剂， 反应 7.0h， 生成 (2R,3S)-3-(dibenzylamino)-5-methylhexan-2-ol
  参考文献：
  名称：

  Discovery of (S)-4-isobutyloxazolidin-2-one as a novel leucyl-tRNA synthetase (LRS)-targeted mTORC1 inhibitor

  摘要：

  A series of leucinol analogs were investigated as leucyl-tRNA synthetase-targeted mTORC1 inhibitors. Among them, compound 5, (S)-4-isobutyloxazolidin-2-one, showed the most potent inhibition on the mTORC1 pathway in a concentration-dependent manner. Compound 5 inhibited downstream phosphorylation of mTORC1 by blocking leucine-sensing ability of LRS, without affecting the catalytic activity of LRS. In addition, compound 5 exhibited cytotoxicity against rapamycin-resistant colon cancer cells, suggesting that LRS has the potential to serve as a novel therapeutic target. (C) 2016 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2016.05.011

文献信息

• Synthesis of Enantiopure (α<i>S</i>,β<i>S</i>)- or (α<i>R</i>,β<i>S</i>)-β-Amino Alcohols by Complete Regioselective Opening of Aminoepoxides by Organolithium Reagents LiAlH₄ or LiAlD₄
  作者：José M. Concellón、Pablo L. Bernad、Virginia del Solar、José Ramón Suárez、Santiago García-Granda、M. Rosario Díaz

  DOI：10.1021/jo0606756

  日期：2006.8.1

  reaction of chiral (2R,1‘S)- or (2S,1‘S)-2-(1-aminoalkyl)epoxides, 1 or 2 with a variety of organolithium compounds to obtain the corresponding (αS,βS)- or (αR,βS)- β-amino alcohols in enantiopure form is reported. In both cases, the opening of the oxirane ring at C-3 proceeded with total regioselectivity. Moreover, the ring opening of aminoepoxides 1 or 2 by hydride (utilizing LiAlH4) to obtain the corresponding

  手性（2 R，1 'S）-或（2 S，1 'S）-2-（1-氨基烷基）环氧化物1或2与多种有机锂化合物的反应，以获得相应的（αS，β小号） -或（α [R，β小号） - β-氨基在对映体纯形式的醇被报告。在这两种情况下，在C-3处的环氧乙烷环的打开都具有完全的区域选择性。此外，通过氢化物（利用LiAlH 4）使氨基环氧化物1或2开环，得到相应的（2 S，3 S）-或（2 R还描述了，3 S）-3-氨基烷基-2-醇。的反应1或2与LiAlD 4代替的LiAlH的4得到相应的（2小号，3小号） -或（2 - [R，3小号）-3-氨基-1- deuterioalkan -2-醇。
• Stereoselective Deprotonation of Chiral and Achiral 2-Aminoalkyl Carbamates: Synthesis of Optically Active β-Amino Alcohols via 1-Oxy-Substituted Alkyllithium Intermediates
  作者：Jörg Schwerdtfeger

  DOI：10.1055/s-1999-3575

  日期：1999.9
• Reetz, Manfred T.; Drewes, Mark W.; Schmitz, Alfred, Angewandte Chemie, 1987, vol. 99, # 11, p. 1186 - 1188
  作者：Reetz, Manfred T.、Drewes, Mark W.、Schmitz, Alfred

  DOI：——

  日期：——
• Non-racemizing synthesis and stereoselective reduction of chiral α-amino ketones
  作者：M.T. Reetz、M.W. Drewes、K. Lennick、A. Schmitz、X. Holdgrün

  DOI：10.1016/0957-4166(90)90037-b

  日期：1990.1
• Schwerdtfeger, Joerg; Hoppe, Dieter, Angewandte Chemie, 1992, vol. 104, # 11, p. 1547 - 1549
  作者：Schwerdtfeger, Joerg、Hoppe, Dieter

  DOI：——

  日期：——